Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004235 |
---|---|
Receipt number | R000005091 |
Scientific Title | Phase ll trial of Amrubicin in Patients with Priviously Treated Advanced Squamous Cell Lung Cancer |
Date of disclosure of the study information | 2010/10/01 |
Last modified on | 2013/11/06 19:49:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/19 20:09:11 | ||
2 | Update | 2010/09/21 07:21:44 | Public title Acronym |
|
3 | Update | 2010/09/21 07:22:48 | Narrative objectives1 |
|
4 | Update | 2010/09/21 07:23:45 | Key exclusion criteria |
|
5 | Update | 2010/09/21 07:25:10 | Institute |
|
6 | Update | 2010/10/01 06:57:15 | Recruitment status |
|
7 | Update | 2011/08/24 20:11:55 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2012/03/27 20:52:43 | ||
9 | Update | 2012/03/27 20:53:30 | Last follow-up date |
|
10 | Update | 2013/11/06 19:49:01 | Recruitment status Last follow-up date |